Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:antiSubmarineWarfare |
addressed in trials
|
| gptkbp:approves |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:clinicalTrials |
December 2020
over 30,000 Phase 3 |
| gptkbp:communityImpact |
critical in controlling pandemic
|
| gptkbp:contraindication |
rare allergic reactions
|
| gptkbp:developedBy |
gptkb:Moderna,_Inc.
|
| gptkbp:diseaseResistance |
Yes
generally high cold chain logistics efforts to include diverse populations |
| gptkbp:dosageForm |
two doses
|
| gptkbp:emergencyServices |
Yes
|
| gptkbp:endOfProduction |
billions of doses annually
|
| gptkbp:evaluates |
94.1% in clinical trials
|
| gptkbp:expansion |
Yes
|
| gptkbp:geographicalFeature |
Yes
|
| gptkbp:hasAuthorityOver |
December 18, 2020
|
| gptkbp:hasCitedPatent |
10 doses
|
| gptkbp:hasLocalCuisine |
18 years and older
|
| gptkbp:hasResearchFocus |
variant strains of SARS-CoV-2
|
| gptkbp:historicalResearch |
gptkb:National_Institutes_of_Health
|
| https://www.w3.org/2000/01/rdf-schema#label |
Moderna vaccine
|
| gptkbp:insuranceAccepted |
conducted
|
| gptkbp:isTestedFor |
critical in pandemic response
|
| gptkbp:launchDate |
January 2020
|
| gptkbp:lengthOverall |
planned
|
| gptkbp:manufacturer |
gptkb:Moderna,_Inc.
|
| gptkbp:notable_player |
ongoing efforts
various global health organizations preventive vaccine multiple health authorities can be stored in standard freezers lipid nanoparticle-encapsulated mRNA reduces severe disease risk significant investment from governments significantly reduced COVID-19 cases |
| gptkbp:patentFamily |
Yes
|
| gptkbp:providesSupportFor |
multiple countries
|
| gptkbp:researchAndDevelopment |
U.S._government_funding
|
| gptkbp:route |
intramuscular injection
|
| gptkbp:safetyFeatures |
ongoing
|
| gptkbp:scientificName |
gptkb:Spikevax
|
| gptkbp:sideEffect |
fatigue
headache muscle pain fever joint pain |
| gptkbp:storage |
-20_degrees_Celsius
|
| gptkbp:surveillanceEquipment |
over 70 countries
|
| gptkbp:takesPlaceIn |
complex_logistics_involved
|
| gptkbp:targets |
gptkb:COVID-19
|
| gptkbp:type |
mRNA vaccine
|